Page 8 - Read Online

Conflicts of interest stem cells. Curr Opin Genet Dev 2016;38:110-7.
There are no conflicts of interest. 7. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou
M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K,
REFERENCES Christofk H, Mischel PS, Pajonk F. Metabolic state of glioma
stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A
2011;108:16062-7.
1. Skvortsova I, Debbage P, Kumar V, Skvortsov S. Radiation 8. Lagadec C, Dekmezian C, Bauché L, Pajonk F. Oxygen levels do
resistance: cancer stem cells (CSCs) and their enigmatic pro- not determine radiation survival of breast cancer stem cells. PLoS
survival signaling. Semin Cancer Biol 2015;35:39-44.
2. Skvortsov S, Debbage P, Skvortsova I. Proteomics of cancer stem One 2012;7:e34545.
cells. Int J Radiat Biol 2014;90:653-8. 9. Gardane A, Poonawala M, Vaidya A. Curcumin sensitizes
3. Skvortsov S, Debbage P, Lukas P, Skvortsova I. Crosstalk between quiescent leukemic cells to anti-mitotic drug 5-fluorouracil by
DNA repair and cancer stem cell (CSC) associated intracellular inducing proliferative responses in them. J Cancer Metasta Treat
pathways. Semin Cancer Biol 2015;31:36-42. 2016;2:245-52.
4. Clevers H. The cancer stem cell: premises, promises and challenges. 10. Vaidya A. The quintessential quiescence of cancer stem cells:
Nat Med 2011;17:313-9. a struggle towards better treatment. J Cancer Metasta Treat
5. Dingli D, Michor F. Successful therapy must eradicate cancer stem 2016;2:243-4.
cells. Stem Cells 2006;24:2603-10. 11. Kim YJ, Siegler EL, Siriwon N, Wang P. Therapeutic strategies for
6. Margineantu DH1, Hockenbery DM. Mitochondrial functions in targeting cancer stem cells. J Cancer Metasta Treat 2016;2:233-42.

232
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ July 8, 2016 ¦